Jeymi Tambiah

Jeymi Tambiah is the Senior Vice President of Medical Affairs at Samumed. Jeymi has over 10 years of experience in the pharmaceutical and biotechnology industries. Jeymi has worked on developing procedures and batch records for the formulation of final drug products, including live viral vaccines for Dengue, H1N1, H1N3, Respiratory Syncytial Virus, and more. Jeymi has also served as a subject matter expert during audits from the FDA, USDA, EMA, and all pharmaceutical clients. Prior to their current position, they worked as a biotechnologist at Merck where they were responsible for product development and hands-on processing of the live viral vaccine, Varivax. Jeymi is certified in aseptic gowning and aseptic technique and has maintained and reviewed executed batch records prior to submission to quality assurance.

Jeymi Tambiah graduated from Ursinus College with a B.S. in Biology, Biostatistics, and Pre-medicine. Jeymi is certified from the Association of Clinical Research Professionals in CCRA.

Jeymi Tambiah reports to Osman Kibar, CEO. They are on a team with Michael A. White - Chief Scientific Officer, Steve Svitenko - VP, Commercial Head, Musculoskeletal, and Gary Choy - VP, Marketing.